The global biohacking landscape demonstrates significant geographic variation in adoption rates, preferred interventions, regulatory environments, and market maturity that shape regional business strategies. North American markets, particularly the United States, lead in market size and innovation driven by technology industry concentration, entrepreneurial culture, venture capital...